Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ · Healthcare
Black Diamond Therapeutics, Inc. Total Liabilities 2018–2025
Black Diamond Therapeutics, Inc. annual/quarterly total liabilities history from 2018 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Black Diamond Therapeutics, Inc. total liabilities for the quarter ending December 31, 2025 were 30.8M, a 21.74% decrease year-over-year.
- Black Diamond Therapeutics, Inc. total liabilities for 2025 were 30.8M, a 21.74% decrease from 2024.
- Black Diamond Therapeutics, Inc. total liabilities for 2024 were 39.4M, a 79.60% increase from 2020.
- Black Diamond Therapeutics, Inc. total liabilities for 2020 were 21.9M, a 349.11% increase from 2019.
- Black Diamond Therapeutics, Inc. total liabilities for 2019 were 4.9M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Black Diamond Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $31 |
| 2024 | $39 |
| 2020 | $22 |
| 2019 | $5 |
| 2018 | $7 |
| Black Diamond Therapeutics, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $31 |
| 2024-12-31 | $39 |
| 2020-12-31 | $22 |
| 2019-12-31 | $5 |
| 2018-12-31 | $7 |
Black Diamond Therapeutics, Inc. Total Liabilities — FAQ
Black Diamond Therapeutics, Inc. (BDTX) total liabilities over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BDTX's total liabilities history?
The chart and table above show Black Diamond Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.